脱兎
liked
Massive selling of Call options for NVIDIA stock, price falls from all-time high.January 8, 2025 6:20 AM JST
Before the announcement at CES by Juan, the CEO, there was a trend of buying Calls.
Volume of Call options is 1.5 times the daily average, actively selling for February expiration.
As NVIDIA, a leading semiconductor company for Artificial Intelligence (AI), saw its stock price hit a record high since November last year before faltering, investors sold a large amount of Call options (rights to buy) for the company's shares on the 7th.
Shortly after trading began, Call options expiring on January 17 (with a strike price of $140) of around 0.2 million contracts, and Call options expiring on February 21 (ranging from $159 to $165) were traded in quantities of 0.6 million to 0.7 million contracts. According to Chris Murphy, co-head of derivative strategy at Susquehanna International Group, most of the Call options were sold.
These sales seem to have reversed the trend of a significant increase in buying Call options in the days leading up to the presentation by NVIDIA's CEO Jensen Huang at the technology trade show Consumer Electronics Show (CES) a few business days before.
Before the announcement at CES by Juan, the CEO, there was a trend of buying Calls.
Volume of Call options is 1.5 times the daily average, actively selling for February expiration.
As NVIDIA, a leading semiconductor company for Artificial Intelligence (AI), saw its stock price hit a record high since November last year before faltering, investors sold a large amount of Call options (rights to buy) for the company's shares on the 7th.
Shortly after trading began, Call options expiring on January 17 (with a strike price of $140) of around 0.2 million contracts, and Call options expiring on February 21 (ranging from $159 to $165) were traded in quantities of 0.6 million to 0.7 million contracts. According to Chris Murphy, co-head of derivative strategy at Susquehanna International Group, most of the Call options were sold.
These sales seem to have reversed the trend of a significant increase in buying Call options in the days leading up to the presentation by NVIDIA's CEO Jensen Huang at the technology trade show Consumer Electronics Show (CES) a few business days before.
Translated
13
1
脱兎
liked
$Tesla (TSLA.US)$
Good evening meowThe market is closed tonight, so the forecast for Friday tomorrow. Meow.
No changes from last night.Still in two ABC patterns.
I'm concerned about the bounce touching 387.47 and ending at 392.93.
A bounce at 383/378 is also possible, but in that case, it would be a pattern towards wave C rally heading to 431.
At the moment, if it falls below 387.47, it could reach 383.38/380.15/378.18/374.32.
In the worst case scenario, if it loses the swing low of 373.05, it could go down to 367.25/348.77.
Currently, it needs to surpass 402.17, hold & break 402.50, and maintain above 405.15 in order to alleviate downward pressure.
As a minimum point, it needs to hold above 378.18 without losing 373.
See you later.Goodbye.
Good evening meowThe market is closed tonight, so the forecast for Friday tomorrow. Meow.
No changes from last night.Still in two ABC patterns.
I'm concerned about the bounce touching 387.47 and ending at 392.93.
A bounce at 383/378 is also possible, but in that case, it would be a pattern towards wave C rally heading to 431.
At the moment, if it falls below 387.47, it could reach 383.38/380.15/378.18/374.32.
In the worst case scenario, if it loses the swing low of 373.05, it could go down to 367.25/348.77.
Currently, it needs to surpass 402.17, hold & break 402.50, and maintain above 405.15 in order to alleviate downward pressure.
As a minimum point, it needs to hold above 378.18 without losing 373.
See you later.Goodbye.
Translated
21
4
I can't believe there are so many remarkable investment opportunities!Click to see the investment outlook for 2025 >>
Translated
...But lately I've been feeling quite down, so I'd like to regain some energy, I should be able to do more. The clinical results of Novo-Nordisk A/S are not significantly bad, but it seems like a disappointment sell due to the expectation of surpassing Eli Lilly and Co in results. Nevertheless, isn't the drop too excessive?
Translated
6